THE UNITED STATES PHARMACOPEIAL CONVENTION for THE UNITED STATES PHARMACOPEIAL CONVENTION
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Advise on standards setting verification, overseas programs, and quality medicines - activities related to drugs, dietary supplements, food ingredients, and compounding HR 934, Personal Drug Importation Fairness Act of 2017; provisions related to importation. HR 1020, Compassionate Freedom of Choice Act of 2017; provisions related to importation. S 92/S 64, Safe and Affordable Drugs from Canada Act of 2017; provisions related to importation. S 183, Short on Competition Act; provisions related to importation. S. 469, the Affordable and Safe Prescription Drug Importation Act; provisions related to importation. Medication adherence HR 592/S 109, Pharmacy and Medically Underserved Areas Enhancement Act; provisions related to provider status. User fee agreements HR 749, Lower Drug Costs Through Competition Act; provisions related to generic competition
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARRIE HARNEY New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.